It has been demonstrated in both experimental and human malignancies that hypoxic tumor cells are linked with aggressive disease phenotype. One of the methods to identify these cells is by direct physical measurement of tumor pO 2 . This study compared pO 2 values measured with two systems, the Helzel Hypoximeter (successor of the polarographic Eppendorf electrode) and the Oxford-Optronix OxyLite (fiber-optic probe), in R3327-AT and R3327-AT/tkeGFP tumors. Partial oxygen pressure was measured in individual tumors with either system or in the same tumor with both systems. The similarities and discrepancies in pO 2 measurements between the two systems were also investigated when tumor-bearing animals were breathing pure oxygen. Our data showed a considerable heterogeneity in pO 2 values in each tumor using both the Helzel and OxyLite systems. Similar results were obtained with both systems for the mean and median pO 2 values, and the distributions of pO 2 values within the interval 0 Ͻ pO 2 Ͻ 40 mmHg (the range important for defining tumor hypoxia) were found to be statistically equivalent. However, the frequencies of high pO 2 values (Ͼ40 mmHg) and zero values measured by the two systems were statistically significantly different. ᭧
INTRODUCTION
Hypoxia is commonly found in solid tumors of various origins. The growth of a solid tumor is limited by neovascularization, which is required for oxygen and nutrient supply. Tumors become hypoxic because of uncontrolled proliferation of tumor cells and insufficient neovascularization. Tumor cells that are deprived of oxygen and nutrients could result in a more aggressive tumor phenotype. It has been reported that tumor cells in neuroblastoma, prostate androgen-sensitive adenocarcinoma, and breast ductal carcinoma in situ lose differentiation characteristics during prolifera-tion under hypoxia and develop more traits of malignancy (1) (2) (3) . Hypoxic tumor cells are more likely to be resistant to ionizing radiation and chemotherapeutic agents and possess increased potential for invasion, metastasis and patient mortality (4) (5) (6) (7) (8) (9) (10) . These findings suggest the importance of recognizing oxygen status in tumors before the initiation of cancer therapy.
Various methods have been developed to identify and quantify tumor hypoxia, including invasive techniques such as polarographic needle probes (e.g. Eppendorf pO 2 histogram) (8) , fluorescence-based fiber-optic probes, (e.g. OxyLite) (11, 12) , the comet assay (13) , the in vivo-in vitro clonogenic assay (14, 15) , and nitroimidazole-based hypoxia markers (e.g. pimonidazole, EF5) (16) (17) (18) . In addition to these invasive techniques, positron emission tomography (PET) (19, 20) and single-photon emission computed tomography (SPECT) with CT image fusion (21) hold promise for identifying tumor hypoxia non-invasively at both the global and local level. Many hypoxia-targeting molecules labeled with positron-emitting radionuclides have been developed (19, 20, (22) (23) (24) (25) (26) . In imaging tumor hypoxia in the clinic, non-invasive methods such as PET have many advantages. They can be used serially to observe changes as the tumor grows, can provide three-dimensional distributions for radiotherapy treatment planning, and can be used during and after treatment for evaluation of therapeutic response.
In our laboratory investigations, endeavors have been made to measure tumor tissue pO 2 with the OxyLite system as a means to validate images of tumor hypoxia obtained with PET hypoxia radiotracers. A disadvantage of the OxyLite system is that the probe must stabilize for 1-2 min at each individual measurement location, thereby limiting the amount of data that can be acquired in each animal. In 2003, the Helzel Hypoximeter, a successor of the Eppendorf system, became available commercially. Although tumor pO 2 measurements with the Eppendorf and OxyLite systems have been compared by other investigators (27, 28) , additional systematic and detailed analyses of the similarities and differences between pO 2 measurements obtained with each systems, in particular in the same tumors, is required. In this work, the two probe systems were compared systematically in tumors of different sizes under both normal air-breathing and pure oxygen-breathing conditions so that their performance could be evaluated in tumors with widely disparate hypoxic cell fractions.
MATERIALS AND METHODS

Animals and Tumor Models
Eight-to 10-week-old male BALB/c nude mice purchased from National Cancer Institute Animal Production (Frederick, MD) were housed five per cage in small animal facilities in our Institute. A constant temperature and humidity were maintained. Animal pellets and acidified water were provided ad libitum. Experiments were conducted according to the principles outlined in the Guide for the Care and Use of Laboratory Animals prepared by the Institutional Animal Care and Use Committee and Research Animal Resource Center of MSKCC.
Experimental tumors were derived from R3327-AT Dunning rat prostate anaplastic adenocarcinoma R3327-AT cells and stably transduced cells that constitutively express the tkeGFP reporter gene, R3327-AT/ tkeGFP. This latter cell line showed less hypoxia in our previous study, as shown by 18 F-FMISO PET and autoradiography (22) as well as by pimonidazole immunohistochemical staining and OxyLite probe measurements (data not shown). The tumor cells were maintained in vitro in DMEM (Mediatech, Inc., Herndon, VA) supplemented with 10% fetal calf serum (Gemini Bio-Product, West Sacramento, CA) and an antibiotic mixture of penicillin and streptomycin (Mediatech). Near-confluent cells were trypsinized using 0.05% trypsin plus 0.54 mM EDTA (Mediatech), and single cell suspensions containing 2.0 ϫ 10 7 cells /ml were prepared. Then 2.0 ϫ 10 6 cells in 100 l were transplanted subcutaneously into the right hind limb of each animal. When the tumors became palpable, tumor size was measured by a caliper and the volume was calculated as abc/6, where a, b and c are three mutually perpendicular diameters. Tumors of 5-12 mm average diameter were used for experiments. The number of tumors studied in each experiment is summarized in Table 1 .
Tissue pO 2 Measurement Systems
The first tumor tissue pO 2 measurement device was the polarographic probe system, the Phoenix Tissue Hypoximeter (Helzel Medical Systems, Kaltenkirchen, Germany). This system uses recessed-tip O 2 microelectrodes (29) . The probe is 300 m in diameter at the tip and 500 m in diameter at the shaft with a glass-insulated gold micro-cathode (17 m in diameter) that is recessed and covered with a Teflon membrane (50 m) (30) . The probe was calibrated before each experiment according to the manufacturer's recommendation. Briefly, the probe was placed into a phosphate-buffered saline (PBS)-filled chamber equilibrated with air and nitrogen to achieve the desired partial oxygen pressure to test and validate the probe calibration.
The second tumor tissue pO 2 measurement device was a four-channel fiber-optic oxygen-sensing device (OxyLite 4000, Oxford Optronix, Oxford, UK). The OxyLite probe consists of the dye ruthenium chloride held in a polymer matrix 230 m in diameter at the tip. It operates on the principle of oxygen-induced quenching of the light emitted by the fluorescent dye, with the quenching being dependent on pO 2 . Each OxyLite probe was calibrated by the manufacturer prior to its delivery, and the calibration data were used in the data acquisition. The calibration data were checked by the same procedure described for the Helzel probes.
Anesthetics
The use of halothane, including isoflurane anesthetics, is contraindicated for the Helzel system. Thus we used intraperitoneal injections of an anesthetic mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg) for all pO 2 measurements. Comparison of pO 2 measurements using the OxyLite system and isoflurane inhalation from our previous study (11) with those using ketamine/xylazine in this study showed no significant differences in the average pO 2 values and in the pO 2 distributions between these two approaches.
pO 2 Measurements using the Helzel and OxyLite Systems in Different Tumors during Air Breathing
In the first study, measurements were performed with both pO 2 probe systems in separate tumor-bearing animals. Anesthetized animals were placed in the prone position on a temperature-regulated heating pad that maintained the core (rectal) temperature at approximately 37ЊC. To facilitate probe penetration, a catheter with a 24G3/4 gauge needle (Introcan Safety, B. Bran Medical Inc., Bethlehem, PA) was used to pierce through the skin where the probe was to be inserted.
For measurements with the Helzel system, when the calibration was completed, the probe was attached to the motor connector, which was affixed to the micromanipulator stand. The electrode probe was also introduced vertically into the tumor via the catheter described earlier. Advancing a probe through the tissue was controlled by computer and typically consisted of a 1.0-mm forward and 0.3-mm retraction motion, so as to decompress the tissue at the measurement site. The probe automatically performs multiple measurements depending on the tumor size. Measurements were made along five to eight parallel tracks in each tumor.
For the OxyLite system, a probe attached to a micromanipulator was inserted into the tumor through the catheter. Measurements were made by advancing the probe in incremental steps of 1.0 mm each. Tissue compression was minimized by advancing the probe 0.2 mm deeper than the measurement step (a total of 1.2 mm) and retracting it 0.2 mm. At the first measurement point after the probe insertion, pO 2 readings were often unstable, and they became stable only after 1-5 min (11). Fluctuations also occurred as the probe advanced; thus measurements were recorded when the readings became stable for Ͼ10 s. Similar to the Helzel system, measurements were made along five to six parallel tracks in each tumor. The mean and median pO 2 values were calculated for the set of values for each individual tumor.
pO 2 Measurements using the Helzel and OxyLite Systems in the Same Tumors during Air Breathing
In the second experiment, pO 2 values were measured in the same tumors using both systems. For this purpose, the measurement procedure was modified slightly. Each anesthetized animal bearing either an R3327-AT or an R3327-AT/tkeGFP tumor was placed on the temperature-regulated heating pad. The tumor size was measured and a line was drawn along the largest longitudinal dimension. The pO 2 measurements were performed with the Helzel and OxyLite systems in parallel trajectories along the line in an interleaved manner, and four trajectories were made with each system on each tumor. The order of the measurements was reversed for each subsequent animal to avoid possible bias. Measurements were made by advancing the probe in incremental steps of 0.5 mm each. Nine R3327-AT and 19 R3327-AT/tkeGFP tumors were used to compare the two systems.
pO 2 Measurements using the Helzel and OxyLite Systems in the Same Tumors in Pure Oxygen-Breathing Animals
In a third experiment, we attempted to evaluate the behavior of both probes under conditions in which the animals were switched to breathing 100% oxygen, since this had been shown to significantly reduce tumor hypoxia in other studies (11, 31) . Our pilot study in which the tumor pO 2 was measured continuously illustrated that carbogen or pure oxygen breathing increased tumor pO 2 readings and that this increase reached a plateau within 45 min. Thus, in these experiments, pO 2 measurements were started 1 h after the initiation of oxygen breathing with i.p. ketamine/xylazine anesthesia. Measurements using both the OxyLite and Helzel systems were performed on a total of six R3327-AT tumor-bearing mice breathing oxygen.
Statistical Methods
In experiment 2, a series of pO 2 measurements were obtained for each of the two systems along parallel tracks every 0.5 mm for up to 10 mm depth. The scattergram data are shown in a dot plot using an indexing set, calculated as [40· mouse ϩ 20 · (track Ϫ 1) ϩ depth Ϫ 20]/40, on the x axis with the pO 2 values on the y axis. For the air-breathing mice, a large proportion of the recorded pO 2 values are zero plus the measurement error. Since the measurement errors depend on the system, a systemdependent threshold was used to designate these low values as zeros. For each mouse the proportion of values that were zero was calculated and the two systems were compared using the Wilcoxon signed-rank test. The larger values were pooled and their distribution was obtained using density estimation (32) . These were compared using the Wilcoxon rank-sum test. For the pure oxygen-breathing mice in experiment 3, there were relatively few zero values, thus allowing for an assessment of the correlation between the two systems by comparing the measurements from the same depth along the parallel tracks for the two systems. These data are shown in a scatterplot. The OxyLite system saturates near 100, and thus high values get truncated and are flagged using a threshold. The values within the low and high thresholds were used to obtain the distribution of pO 2 using density estimation.
For comparisons with previously published data from our group and others, the mean and median pO 2 values Ϯ 1 SD were calculated separately for each experimental group. During the data processing to determine the mean or median pO 2 values, pO 2 readings of less than zero were treated as zero.
RESULTS
Histogram of pO 2 Measurements using the Helzel and OxyLite Systems in R3327-AT Tumors of Different Sizes
To compare the two systems, pO 2 distributions were measured in R3327-AT tumors of different sizes. In experiment 1, a total of 19 and 21 R3327-AT tumors were used for measurements with the Helzel and OxyLite systems, respectively. The total numbers of measurement points with the Helzel and OxyLite were 1341 and 900, respectively. Table 2 shows the percentages of pO 2 readings below 2.5, 5.0 and 10.0 mmHg, the range of pO 2 readings, and the mean and median pO 2 values of all the tumors measured separately with either the Helzel or the OxyLite system.
Histograms of pO 2 readings measured by the two systems are shown in Fig. 1a (Helzel) and b (OxyLite) for five tumor size groups. The data presented are for tumor groups that are fairly well matched in size and number. A comparison of that two panels shows that the two pO 2 measurement systems yielded similar data for the distributions of frequency (percentage of readings). As expected, the percentage of readings below 2.5 mmHg increased from 15-20% for the smallest sizes to above 80% for the largest tumors, and this was true for both pO 2 systems. The increase was most drastic from the smallest tumor size group to the next size group, concomitant with a decrease in the incidence of higher pO 2 readings.
Comparison of pO 2 Measured in the same Tumor with both Helzel and OxyLite Systems during Air Breathing
In experiment 2, pO 2 levels were measured with both systems in the same tumor. In total, nine animals with R3327-AT tumors (ranging from 360 mm 3 to 930 mm 3 ) and 19 animals with R3327-AT/tkeGFP tumors (ranging from 170 mm 3 to 1500 mm 3 ) were studied. In each tumor, eight trajectories were used, four each for the Helzel and the OxyLite, with a total of 52-84 measurements per system in each tumor. Figure 2 shows the data acquired with both the Helzel and OxyLite systems in the form of dot plots, which allow all of the measured data to be plotted on a single graph. The data for the mice with R3327-AT tumors are shown on the top row and those for the mice with R3327-AT/ tkeGFP tumors on the bottom row. The results for the Helzel system (panels a and c) are noisier around zero than those for the OxyLite system, and thus a threshold of 2.5 and 1, respectively, was used to identify the zeros. There were significantly more zero pO 2 values for the R33217-AT tumors measured with the OxyLite system than for those measured with the Helzel system (P Ͻ 0.01). Figure 2c and d shows the results for the 19 R3327-AT/ tkeGFP tumor-bearing animals for the Helzel and OxyLite probes. The mean percentages (Ϯ SD) of readings both Ͻ2.5 and Ͻ5.0 mmHg, stratified according to tumor volume, using the Helzel and OxyLite systems are given in Table 3 for the R3327-AT tumors. No statistically significant differences were observed between the two probe systems in R3327-AT/tkeGFP tumors (P ϭ 0.138).
The majority of the data points are zero or insignificantly above or below zero for all but the smallest xenografts. Therefore, the statistical analysis was divided into an anal- ysis of the percentage of measurements at zero for each of the pO 2 measurement devices and an analysis of whether the distribution of non-zero values was significantly different. The frequency of zero values with the OxyLite probe was significantly greater than that obtained with the Helzel probe system for measurements on the R3327-AT tumors (P ϭ 0.039), but no significant difference was found for the R3327-AT/tkeGFP tumor (P ϭ 0.798). There are differences in the histology between the two R3327-AT tumor cell lines, with slightly more hypoxia and necrosis being observed in tumors derived from the parental line. The results of the second part of the analysis are shown in Fig.  3 , which shows the distribution density of non-zero pO 2 values for the R3327-AT and R3327-AT/tkeGFP tumors. In this analysis, we also found a small significant difference between the distributions of pO 2 values for the R3327-AT tumors (P Ͻ 0.01), but no significant difference was observed for the distribution measured by the two systems for the larger data set obtained for the R3327-AT/tkeGFP tumors (P ϭ 0.138).
Comparison of pO 2 Measurements with the Helzel and OxyLite Systems in the Same Tumors during Pure Oxygen Breathing
In experiment 3, both pO 2 probe systems were evaluated in tumors to compare their performance upon perturbation of the pO 2 gradients by performing measurements in the same tumors with both probes 60 min after the initiation of oxygen breathing. The measurements were made in alternating tracks with both the Helzel and OxyLite systems 
FIG. 3.
The distributions of non-zero pO 2 for the Helzel system (solid line) and OxyLite system(dashed line) are shown for the R3327-AT (left panel) and R3327-AT/tkeGFP tumors (right panel). The pO 2 values for the R3327-AT tumors were significantly lower for the OxyLite system than for the Helzel system (P Ͻ 0.01). There was no significant difference in the R3327-AT/tkeGFP tumors (P ϭ 0.138). and 10.6 for the Helzel system and 7.9, 9.2 and 13.6 for the OxyLite system. The distributions of pO 2 values measured with the two probe systems were similar for all animals except number 5. Also, for mice 1-4 and 6, no significant difference was observed between the Helzel and OxyLite probes (P ϭ 0.508). Figure 4c shows a scattergram of paired pO 2 readings for comparable depths along parallel tracks measured alternately with the Helzel (abscissa) and OxyLite (ordinate) pO 2 probe systems for all mice except animal 5. The data show no correlation between the two measurement systems. This is to be expected, because the distance between the parallel tracks is 1 mm, which is large compared to the oxygen gradients known to exist in tumors. pO 2 is believed to fall from 140 mm to 0 mmHg over a distance of about 0.2 mm. Figure 4d shows the distribution density of non-zero pO 2 measurement points for the two probes. This figure shows the similarity in the spectrum of measured values and demonstrates the statistical equivalence of the two measurement devices.
DISCUSSION
The present study was performed in conjunction with our research to validate non-invasive imaging measurements of tumor hypoxia. At the beginning of our studies, only the OxyLite system was available commercially. In previous studies, we evaluated the effects of various anesthetics on OxyLite probe tumor pO 2 measurements (11, 14) . This study demonstrated the reliability of OxyLite system measurements in animals under sustained isoflurane anesthesia. Whereas the OxyLite probe has certain advantages, including the ability to measure pO 2 at individual locations over prolonged periods, because the device does not consume oxygen (11, 28, 33) , the long stabilization time requiring 1-2 min per reading is a major limitation, rendering its use laborious and time-consuming. The OxyLite probe can also be used in combination with magnetic resonance imaging and positron emission tomography (19, 20) .
The Eppendorf pO 2 measurement system has been used successfully by many investigators (9, 10) , but it ceased to be available commercially about 10 years ago. The Helzel polarographic probe system (based on the same principle as the Eppendorf precursor) became available commercially in 2003. It has the advantage of a more rigid metal probe casing and a more efficient data acquisition process with the use of a stepping motor and computer control. However, it cannot be used in steady-state measurements because of oxygen consumption during the read-out process.
In the present study, we performed a systematic and detailed analysis of the similarities and differences between pO 2 measurements obtained with the Helzel and OxyLite systems. We performed a preliminary experiment to validate the similarity of readings within the two systems in our R3327-AT tumor xenograft model as well as to confirm the compatibility of our data with published data obtained by others from different tumor xenograft models. One unique aspect of this study was that we conducted experiments in which pO 2 measurements were performed using both systems in the same tumors. These measurements were done in animals under normal air-breathing conditions and after the pO 2 profiles were perturbed by allowing the animals to breathe pure (100%).
Consistent with the previous findings in this and other laboratories, the present study indicated that tumors Ͼ200 mg are extremely hypoxic in air-breathing mice (Figs. 1  and 2 ). Significant heterogeneity in oxygenation status in each measurement track was observed with both pO 2 measurement systems (Figs. 2 and 3) . Our findings support the The scatterplot of the data shows that the two are not related, which is to be expected since the measurements are local at micrometer levels while the points compared are 1 mm apart. The lower right panel shows that while pO 2 values were not correlated, the distributions of the values from the two systems are comparable.
overall equivalence of the two pO 2 probes as reported by Sedden et al. (27) but also the differences at the limits of operation leading to unequivalency, as discussed by Braun et al. (28) . Specifically, the pooled pO 2 data shown in Tables 2 and 3 indicated close similarities between the pO 2 frequency distributions measured by the two systems. Detailed statistical analysis of (1) the number of zero readings from each of the two probe systems and (2) the distribu-tions of non-zero pO 2 readings exhibited some statistically significant discrepancies. The small number of zero measurements under oxygen-breathing conditions allows the performance of the two probe systems to be compared over a full range of pO 2 values. In oxygen-breathing animals, these two systems yielded very similar mean or median pO 2 readings and percentages of pO 2 with different thresholds.
The polarographic electrode and fiber-optic probe differ in many respects, including the mechanism of pO 2 measurement, and the tissue volume sensed by the probe tip, the speed and process of pO 2 readings. The fiber-optic probe is most accurate near 0 mmHg, and its signal-to-noise ratio becomes progressively lower with increasing pO 2 , especially above 50 mmHg (34) . In contrast, the signal of the polarographic electrode is directly proportional to the pO 2 value being measured and is therefore subject to the greatest errors at the lowest pO 2 readings (27) . Considering many these differences, it is reassuring that the two systems give comparable distributions of pO 2 values measured in a large number of tumors.
CONCLUSIONS
In this study, we made pO 2 measurements with both systems in the same tumors measurements in nine parental R3327-AT tumors, 19 R3327-AT/tkeGFP tumors, and an additional six R3327-AT tumors in mice breathing 100% oxygen. There was a slight but significant difference observed for the parental R3327-AT prostate cancer cell line, but no difference was observed in the larger group of tumors grown from a genetically modified subclone, R3327-AT/tkeGFP. Data acquired with the two systems in pure oxygen-breathing animals extended the range of the comparison of pO 2 values and provided more evidence of the equivalence of the Helzel and OxyLite pO 2 measuring systems.
In summary, we demonstrated that Helzel and OxyLite systems provide comparable assessments of tumor oxygenation. The differences in their physical and operational characteristics can be translated into advantages or disadvantages depending on the application. Our conclusion is that the two pO 2 probe systems complement each other and can be used interchangeably in the measurement of tumor hypoxia.
